International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report)’s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.14 and traded as high as $0.15. International Stem Cell shares last traded at $0.15, with a volume of 150 shares changing hands.
International Stem Cell Trading Down 3.0%
The firm has a market cap of $1.17 million, a P/E ratio of -3.66 and a beta of -0.02. The business’s fifty day moving average price is $0.14 and its two-hundred day moving average price is $0.14.
International Stem Cell (OTCMKTS:ISCO – Get Free Report) last released its quarterly earnings results on Thursday, August 14th. The biotechnology company reported $0.01 earnings per share for the quarter. The business had revenue of $2.45 million for the quarter.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Further Reading
- Five stocks we like better than International Stem Cell
- What Are the FAANG Stocks and Are They Good Investments?
- Archer’s Recent String of Victories Signals a New Phase of Growth
- Overbought Stocks Explained: Should You Trade Them?
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- Where to Find Earnings Call Transcripts
- The Best AI for Picking Stocks, Ranked by Performance
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
